Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
7.31
Nov 04 • 3:59 PM ET Dollar change+1.03 Percentage change(16.40%)
Aftermarket Close
7.30
Aftermarket • 7:30 PM ET Dollar change-0.01 Percentage change(-0.14%)
Today, 1:03 PMQ3 beat and raised outlook extend AdaptHealth 17% higher during regular hours
Index
RUT
Market Cap
996.67M
Enterprise Value
2.97B
Income
-404.04M
Sales
3.15B
Book/sh
9.18
Cash/sh
0.59
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
10900
IPO
May 24, 2018
P/E
-
Forward P/E
-
PEG
-
P/S
0.32
P/B
0.80
P/C
12.35
P/FCF
12.17
EV/EBITDA
5.08
EV/Sales
0.94
Quick Ratio
0.98
Current Ratio
1.13
Debt/Eq
1.67
LT Debt/Eq
1.61
Option/Short
Yes / Yes
EPS (ttm)
-2.97
EPS next Y
-0.05
EPS next Q
-0.04
EPS this Y
-125.86%
EPS next Y
71.71%
EPS next 5Y
-
EPS past 3/5Y
- 29.83%
Sales past 3/5Y
2.99% 25.16%
EPS Y/Y TTM
-636.28%
Sales Y/Y TTM
-3.17%
EPS Q/Q
-790.10%
Sales Q/Q
-9.10%
Insider Own
36.66%
Insider Trans
0.08%
Inst Own
71.66%
Inst Trans
-4.44%
ROA
-10.01%
ROE
-30.23%
ROIC
-12.61%
Gross Margin
14.85%
Oper. Margin
3.24%
Profit Margin
-12.82%
SMA20
19.27%
SMA50
23.14%
SMA200
-19.93%
Trades
Shs Outstand
133.53M
Shs Float
86.36M
52W High
13.43 -45.57%
52W Low
5.21 40.31%
Volatility
8.87% 5.43%
ATR (14)
0.36
RSI (14)
72.73
Beta
1.31
Rel Volume
1.95
Avg Volume
3.24M
Volume
6,324,774
Perf Week
21.23%
Perf Month
26.69%
Perf Quarter
20.93%
Perf Half Y
-35.99%
Perf YTD
-26.61%
Perf Year
-31.49%
Perf 3Y
-13.70%
Perf 5Y
-71.72%
Perf 10Y
-
Prev Close
6.28
Price
7.31
Change %
16.40%
Consensus
Strong Buy
Avg. Price Target
$8.86
Implied Upside
+21.2%
Analysts10incl. previous ratings
Rating Distribution6 Buy · 3 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jan 08, 2024Downgrade
JEF logoJJefferies
Buy → Hold$14.50 → $8+9.4%
Nov 08, 2023Downgrade
BAC logoBBofA Securities
Neutral → Underperform$9.50 → $6.50-11.1%
May 10, 2023Downgrade
SF logoSStifel
Buy → Hold$18 → $11+50.5%
May 10, 2023Downgrade
DB logoDDeutsche Bank
Buy → Hold$28 → $11.30+54.6%
May 09, 2023Downgrade
BAC logoBBofA Securities
Buy → Neutral$21 → $12+64.2%
Sep 27, 2021Initiated
SSVB Leerink
Outperform$30+310.4%
Jul 14, 2021Upgrade
RRobert W. Baird
Neutral → Outperform$30 → $36+392.5%
Apr 13, 2021Downgrade
RRobert W. Baird
Outperform → Neutral
Mar 18, 2021Initiated
TFC logoTTruist
Buy
Jan 26, 2021Initiated
BAC logoBBofA Securities
Buy$46+529.3%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAMET KENNETH ADirectorAug 06 '26Buy6.3823,500149,93048,569Aug 10 08:03 PM
WOLF DALE BDirectorAug 06 '26Buy6.3720,000127,400143,234Aug 10 08:02 PM
WOLF DALE BDirectorAug 07 '26Buy5.8620,000117,20034,000Aug 10 08:02 PM
Schuster III Russell E.Chief Commercial OfficerJul 01 '26Sale10.4411,275117,711125,263Jul 06 04:01 PM
Schuster III Russell E.OfficerJul 01 '26Proposed Sale10.4411,275117,711Jul 01 11:51 AM
Schuster III Russell E.Chief Commercial OfficerJun 01 '26Sale10.0611,275113,426136,538Jun 03 06:43 PM
Schuster III Russell E.OfficerJun 01 '26Proposed Sale10.0611,275113,426Jun 01 12:38 PM
CASHIN RICHARD M JR10% OwnerMar 20 '26Buy9.91447,1004,431,70016,312,698Mar 23 06:25 PM
CASHIN RICHARD M JR10% OwnerMar 19 '26Buy9.947277,22815,865,598Mar 23 06:25 PM
Prast Albert A.Chief Technology OfficerMar 13 '26Option Exercise4.3889,451391,795532,358Mar 16 04:04 PM
CASHIN RICHARD M JR10% OwnerMar 10 '26Buy9.73820,5287,982,67114,638,708Mar 12 09:11 PM
CASHIN RICHARD M JR10% OwnerMar 12 '26Buy9.73689,3366,707,17015,864,871Mar 12 09:11 PM
CASHIN RICHARD M JR10% OwnerMar 11 '26Buy9.73536,8275,222,30715,175,535Mar 12 09:11 PM
WOLF DALE BDirectorFeb 27 '26Buy8.968,00071,680104,235Mar 03 06:41 PM
Rew Richard W. IICLO and General CounselFeb 26 '26Buy8.915,00044,550107,097Feb 27 04:01 PM
Williams David Solomon IIIDirectorDec 04 '25Sale9.435,00047,15045,045Dec 05 05:35 PM
DAVID S WILLIAMSDirectorDec 04 '25Proposed Sale9.435,00047,150Dec 04 04:21 PM
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Conshohocken, PA.
CEO & DirectorMs. Suzanne M. Foster M.P.H.
CTO & Chief Innovation OfficerMr. Albert A. Prast
Chief Commercial OfficerMr. Russell E. Schuster III
Chief Financial OfficerMr. Harriss T. Currie
Chief Operations OfficerMr. Daniel McFadden